The FDA accepted the NDA for AXS-12 for the treatment of cataplexy in narcolepsy, setting a PDUFA target action date of May 1, 2027.

Patients with COPD living in rural communities experienced improvements after a 12-week home-based online rehabilitation program.

AI was everywhere at the recent ATS annual meeting, from speeches to pharmaceutical company exhibits to hands-on AI labs.

The FDA has approved Jideytro for adult patients with pretreated ROS1-positive advanced NSCLC based on results from the ARROS-1 trial.

Researchers evaluated the night-to-night variability of polysomnography-derived metrics in adults with or at high risk for obstructive sleep apnea.

A fifth person has died in a Legionnaires' disease outbreak on Manhattan's Upper East Side, New York City health officials said.

Cannabis beverages are increasingly turning up next to iced tea and sodas; doctors warn the easy access is putting kids at risk.

Patients with HIV infection show increased prevalence of preserved ratio impaired spirometry (PRISm) and restrictive spirometry patterns (RSP), according to study findings publish ...

An estimated 20.6 million new cancer cases occurred worldwide in 2024, with incidence burden expected to increase to 34.4 million by 2050.

The prognostic nutritional index predicted mortality more accurately than 2 other composite inflammatory and nutritional markers in patients with IPF.

A sustained virtual tobacco treatment program nearly doubles the rate of quitting versus usual care within community oncology care settings.